Showing results (1-10 of 129) with videos related to
Sort By:
Pageof 13
Pharmacology & Therapeutics|August 2, 2012
Dipeptidyl peptidase 4 as a therapeutic target in ischemia/reperfusion injuryVeerle Matheeussen, Wolfgang Jungraithmayr, Ingrid De MeesterBiochemical Pharmacology|August 30, 2008
DPP4 inhibitors for diabetes--what next?Anne-Marie Lambeir, Simon Scharpé, Ingrid De MeesterClinica Chimica Acta; International Journal of Clinical Chemistry|March 3, 2007
Dipeptidyl peptidase II (DPPII), a reviewMarie-Berthe Maes, Simon Scharpé, Ingrid De MeesterCancers|February 15, 2022
Validating Cell Surface Proteases as Drug Targets for Cancer Therapy: What Do We Know, and Where Do We Go?Emile Verhulst, Delphine Garnier, Ingrid De Meester, et al.Pharmacology & Therapeutics|March 2, 2019
CD26/DPP4 - a potential biomarker and target for cancer therapyNjanja Enz, Gwendolyn Vliegen, Ingrid De Meester, et al.Biochemical Pharmacology|November 26, 2002
A kinetic study of glucagon-like peptide-1 and glucagon-like peptide-2 truncation by dipeptidyl peptidase IV, in vitroAnne-Marie Lambeir, Paul Proost, Simon Scharpé, et al.Critical Reviews in Clinical Laboratory Sciences|August 2, 2003
Dipeptidyl-peptidase IV from bench to bedside: an update on structural properties, functions, and clinical aspects of the enzyme DPP IVAnne-Marie Lambeir, Christine Durinx, Simon Scharpé, et al.Marine Pollution Bulletin|August 25, 2004
Levels and profiles of PCBs and OCPs in marine benthic species from the Belgian North Sea and the Western Scheldt EstuaryStefan Voorspoels, Adrian Covaci, Johan Maervoet, et al.Advances in Experimental Medicine and Biology|April 5, 2003
CD26/DPP IV in experimental and clinical organ transplantationStephan Korom, Ingrid de Meester, A Belyaev, et al.Veterinary Journal (London, England : 1997)|October 2, 2012
Possible mechanisms for brain natriuretic peptide resistance in heart failure with a focus on interspecies differences and canine BNP biologyLesley Baerts, Nelson Gomez, Marc Vanderheyden, et al.Pageof 13